In the autumn of 2006, the University of Helsinki, the Hospital District of Helsinki and Uusimaa (HUS) and the National Public Health Institute founded the Institute for Molecular Medicine Finland. The purpose of this institute is to generate new knowledge and innovations on disease-causing mechanisms in order to diagnose, treat and prevent diseases and promote public health. It utilizes Finnish clinical and epidemiological material in its research work.
The aim is to assemble research and infrastructure in the fields of molecular medicine, genetics and epidemiology within a major, internationally recognized unit which strengthens and internationalizes the related research and researcher training and accelerates the utilization of research results.
The institute, to which the Finnish Genome Center has been attached, will mainly operate from the Biomedicum Helsinki 2 building. It will network with its Swedish and Norwegian counterparts and the European Molecular Biology Laboratory (EMBL).
The institute’s operations are supported by the Jane and Aatos Erkko Foundation, the City of Helsinki, the Sigrid Jusélius Foundation, Orion Corporation and the Finnish Medical Foundation. Other central biomedical universities and research organizations have the opportunity to join the institute.